Failed to fetch dynamically imported module: https://finance.yahoo.com/assets/_app/immutable/nodes/105.DozQrLpG.js ...
Ipratropium bromide nasal solution (nasal spray), 0.03% gives symptomatic relief in cases associated with allergic and ...
The trial will evaluate the safety and effectiveness of a next-generation vaccine administered through a nasal spray or ...
Keymed Biosciences (HKEX: 02162) today announced the National Medical Products Administration (the "NMPA") of China has recently approved the supplemental ...
KeyMed Biosciences (HKEX: 02162) today announced the National Medical Products Administration (the "NMPA") of China has recently approved the supplemental New Drug Application (the "sNDA") of ...
Discover how a newly recommended immunotherapy works by gradually increasing the body’s resistance to house dust mites.
Nasal irrigation can be a useful addition to the management of chronic upper respiratory conditions, including nasal ...
ARS Pharmaceuticals launched Neffy, the first FDA-approved needle-free epinephrine nasal spray for severe allergic reactions.
Ipratropium bromide nasal solution 0.06% is indicated for symptomatic relief of rhinorrhea associated with the common cold or ...
Should you start taking your allergy medicine now? We VERIFY the answer to that and other common questions about allergy treatments.
Phenotyping children with asthma based on rhinoconjunctivitis symptoms shows that rhinoconjunctivitis may not always be allergy driven.
ALK (ALKB:DC / OMX: ALK B / AKBLF) today announced that the National Institute for Health and Care Excellence (NICE) has recommended the use of ACARIZAX® for the treatment of persistent, moderate to ...